HutchMed launches $602m secondary listing in Hong Kong

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

HutchMed launches $602m secondary listing in Hong Kong

Jonathan Breen
June 18, 2021 08:15 AM
Biotech_PA_575x375_21July.jpg

Biopharmaceutical company HutchMed (China) kicked off the roadshow for its HK$4.68bn ($602.7m) Hong Kong IPO on Friday, placing more than half of the shares in its third listing with cornerstone investors.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Macquarie GroupDeutsche BankCredit SuisseEquity IPOsHealth and BiotechChina Merchants Securities CoEquityChina Merchants Bank CoChina International Capital CorpJefferies LLCHong Kong SARAsiaGreater ChinaNortheast AsiaAsia PacificSRIMorgan StanleyEmerging MarketsHSBC
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article